Resection, biopsy and survival in malignant glial neoplasms, a retrospective study of clinical parameters, therapy and outcome
Devaux B.C., O'Fallon J.R., and Kelly P.J. Resection, biopsy and survival in malignant glial neoplasms, a retrospective study of clinical parameters, therapy and outcome. J Neurosurg 78 (1993) 767-775
Therapy of glioblastoma multiforme, a cumulative experience of 10 years
Obwegeser A., Ortler M., Seiwald M., Ulme H., and Kostron H H. Therapy of glioblastoma multiforme, a cumulative experience of 10 years. Acta Neurochir (Wein) 137 (1995) 29-33
ALA and Photofrin fluorescence-guided resection and repetitive PDT in glioblastoma multiforme: a single centre Phase III randomised controlled trial
Eljamel M.S., Goodman C., and Moseley H. ALA and Photofrin fluorescence-guided resection and repetitive PDT in glioblastoma multiforme: a single centre Phase III randomised controlled trial. Lasers Med Sci 23 (2008) 561-567
Fluorescence-guided surgery with 5-aminolevulenic acid for resection of malignant glioma: a randomized controlled multicentre phase III trial
Stummer W., Oitchimeier U., Meinel T., Wiestler O.D., Zanella F., and Reulen H. Fluorescence-guided surgery with 5-aminolevulenic acid for resection of malignant glioma: a randomized controlled multicentre phase III trial. Lancet Oncol 7 (2008) 392-401
Fluorescence guided resection of glioblastoma multiforme by using 5-aminolevulenic acid induced porphyrins; a prospective study in 52 consecutive patients
Stummer W., Novotny A., Stepp H., et al. Fluorescence guided resection of glioblastoma multiforme by using 5-aminolevulenic acid induced porphyrins; a prospective study in 52 consecutive patients. J Neurosurg 93 (2000) 1003-1013